Damora Therapeutics, Inc. (DMRA)
NASDAQ: DMRA · Real-Time Price · USD
21.60
+0.11 (0.51%)
At close: Nov 2, 2026, 4:00 PM EST
21.39
-0.21 (-0.97%)
Pre-market: Nov 3, 2026, 4:02 AM EST
Damora Therapeutics Market Cap
Damora Therapeutics has a market cap or net worth of $1.33 billion as of November 2, 2026. It is the 8,474th most valuable company in the world and the 2,045th biggest in the United States. Its market cap has increased by 13,653.28% in one year.
Market Cap
1.33B
Enterprise Value
792.97M
1-Year Change
13,653.28%
Global Rank
Country Rank
#2,045 United States
Category
ChartMarket Cap Chart
Since October 29, 2020, Damora Therapeutics's market cap has increased from $368.78M to $1.33B, an increase of 261.60%. That is a compound annual growth rate of 23.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 2, 2026 | 1.33B | 3,528.11% |
| Dec 31, 2025 | 36.75M | 500.17% |
| Dec 31, 2024 | 6.12M | -68.63% |
| Dec 29, 2023 | 19.52M | -33.64% |
| Dec 30, 2022 | 29.42M | -61.57% |
| Dec 31, 2021 | 76.54M | -75.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Oct 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AnaptysBio | 1.44B |
| GH Research | 1.43B |
| Korsana Biosciences | 1.37B |
| Taysha Gene Therapies | 1.35B |
| Omeros | 1.33B |
| Nektar Therapeutics | 1.33B |
| Kardigan | 1.32B |
| LB Pharmaceuticals | 1.28B |